DAABD-AE
4-[2-(N,N-dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole (DAABD-AE) is new derivatization reagent for rapid and specific liquid chromatography tandem mass spectrometric quantification of pristanic acid, phytanic acid, and very long chain fatty acids (i.e. hexacosanoic, tetracosanoic, and docosanoic acids) in plasma.
| Catalog Number | CDX-D0204-M250 |
| Alternative Name(s) | 4-[2-(N,N-Dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole |
| Research Area | Biochemicals, Immunology |
| Molecular Formula | C12H20N6O3S |
| CAS# | 913253-56-2 |
| Purity | >95% |
| Inchi | InChI=1S/C12H20N6O3S/c1-18(2)8-7-15-22(19,20)10-4-3-9(14-6-5-13)11-12(10)17-21-16-11/h3-4,14-15H,5-8,13H2,1-2H3 |
| Inchi Key | QKTBJERNSIEPPM-UHFFFAOYSA-N |
| SMILES | CN(C)CCNS(=O)(=O)C1=CC=C(NCCN)C2=NON=C12 |
| Size | 250 mg |
| Supplier Page | http://www.adipogen.com/cdx-d0204/daabd-ae.html |